AstraZeneca (AZN) - Research Analysts' Recent Ratings Changes
They now have a "buy" rating on the stock. 3/20/2018 - AstraZeneca was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
from Biotech News
They now have a "buy" rating on the stock. 3/20/2018 - AstraZeneca was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments